feed,title,long_url,short_url
Benzinga,Rare Disease Player BridgeBio Pharma's Upside Potential Is Significant According to Citi Analyst - Here's Why,https://benzinga.com/general/biotech/23/11/35652192/rare-disease-player-bridgebio-pharmas-upside-potential-is-significant-according-to-citi-analyst-h,https://da.gd/Wdbl0
Benzinga,"Rivian Stock Upshifts On Strong Q3 Earnings: EPS Beat, Revenue Beat, Increased Production Guidance And More",https://benzinga.com/news/earnings/23/11/35659331/rivian-stock-upshifts-on-strong-q3-earnings-eps-beat-revenue-beat-increased-production-guidance-and,https://da.gd/o2NDKT
